CRISPR Pioneer Jennifer Doudna Reflects on Transformative Genome Editing

Doudna's journey from Hawaii to Nobel Prize highlights the power of curiosity-driven research and the responsibility that comes with scientific breakthroughs.

Published on Feb. 23, 2026

Got story updates? Submit your updates here. ›

In a Priestley Medal address, Jennifer Doudna, the co-inventor of the revolutionary CRISPR gene-editing technology, reflects on her path from growing up in Hilo, Hawaii to leading groundbreaking research at UC Berkeley. Doudna describes how her early fascination with the natural world and the 'hidden processes' of biology led her to become a structural biologist and RNA chemist, ultimately uncovering the CRISPR system's potential as a versatile genome-editing tool. She discusses the ethical obligations that come with such powerful scientific advancements, and how the Innovative Genomics Institute she co-founded is working to responsibly develop CRISPR-based solutions for human health, climate resilience, and sustainable agriculture.

Why it matters

Doudna's story highlights how curiosity-driven, interdisciplinary research can lead to transformative scientific breakthroughs, like the development of CRISPR technology. Her reflections on the ethical considerations around CRISPR also underscore the importance of aligning powerful new tools with societal values to ensure they are used to benefit humanity and the planet, not exacerbate inequality or enable harmful 'enhancements'.

The details

Doudna's fascination with the natural world and biological processes began in her childhood in Hilo, Hawaii. After studying chemistry at Pomona College and earning a PhD in biochemistry at Harvard, she pursued postdoctoral work that shaped her identity as a structural biologist and RNA chemist. Doudna joined the faculty at Yale and then UC Berkeley, where her lab focused on understanding RNA functions. In 2009, she began investigating the CRISPR bacterial immune system, eventually collaborating with Emmanuelle Charpentier to elucidate how the CRISPR-Cas9 system could be repurposed as a powerful, programmable genome-editing tool. Their groundbreaking 2012 publication launched the 'CRISPR revolution' and paved the way for a wide range of CRISPR-based applications in medicine, agriculture, and beyond.

  • In 2009, Doudna began investigating the CRISPR bacterial immune system.
  • In 2012, Doudna and Charpentier published their findings on how CRISPR-Cas9 could be used as a programmable genome-editing tool.
  • In 2020, Doudna and Charpentier were awarded the Nobel Prize in Chemistry 'for the development of a method for genome editing'.

The players

Jennifer Doudna

A biochemist and co-inventor of the CRISPR gene-editing technology, who is a professor at UC Berkeley and co-founder of the Innovative Genomics Institute.

Emmanuelle Charpentier

A French microbiologist who collaborated with Doudna on the development of CRISPR-Cas9 as a genome-editing tool.

Innovative Genomics Institute (IGI)

A joint UC Berkeley–UC San Francisco organization co-founded by Doudna with the goal of realizing the promise of CRISPR genome editing to improve human and planetary health.

Got photos? Submit your photos here. ›

What they’re saying

“I had teachers who encouraged my curiosity, and parents who never questioned my interest in asking how things worked.”

— Jennifer Doudna

“What had begun as a curiosity-driven effort to understand bacterial immunity had revealed something far larger: a versatile, accessible method for editing genomes.”

— Jennifer Doudna

“For me, the core ethical principle is that CRISPR should be used to alleviate suffering and expand opportunity, not to exacerbate inequality or enable frivolous 'enhancements' that undermine our shared humanity.”

— Jennifer Doudna

What’s next

Doudna and the Innovative Genomics Institute will continue to focus on developing next-generation CRISPR tools and delivery systems, as well as applying CRISPR-based approaches to address challenges in human health, agriculture, and climate change.

The takeaway

Doudna's journey from a curious child in Hawaii to a Nobel Prize-winning scientist at the forefront of the CRISPR revolution underscores the power of curiosity-driven research and the responsibility that comes with scientific breakthroughs. Her work highlights how interdisciplinary collaboration and a commitment to public benefit can transform molecular discoveries into transformative technologies that improve lives and the planet.